Ahuva Cices is a Dermatology physician affiliated with Icahn School of Medicine at Mount Sinai. OpenAlex indexes 45 publications with 214 citations (h-index 9); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5 E 98th St Fl 5
New York, NY 100296501
Telephone
212-241-9728Provider last certified this registry record 9 Apr 2026.
Clinical trials
- Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria
Sponsor: Ahuva D Cices
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
34 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year202533 payments$16,254openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year202528 payments
- Incyte CorporationProgram year202535 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
30.4%Azole Antifungal24.4%Ketoconazole100%Part D≥140 patientsTetracycline-class Drug2.1%Doxycycline Hyclate59%Doxycycline Monohydrate41%Part D<11 patients+ 2 more classes in this area
Dermatology
27.3%Corticosteroid15.9%Triamcinolone Acetonide93%Fluocinolone Acetonide7%Part D<11 patientsalpha-Hydroxy Acid7.1%Ammonium Lactate100%Part D≥51 patients+ 1 more class in this area
Sensory organs
18.8%Corticosteroid18.8%Hydrocortisone56%Clobetasol Propionate44%Part D≥90 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- P0453 Association between Inflammatory Bowel Disease and Hidradenitis Suppurativa: An international multicenter retrospective study
Journal of Crohn s and Colitis
2026 - Upadacitinib for the Treatment of Cutaneous Crohn's Disease Presenting as Lymphangioma Circumscriptum
ACG Case Reports Journal
2026 - Assessing the Quality of Rosacea Treatment Content on TikTok: A Cross-Sectional Analysis
SKIN The Journal of Cutaneous Medicine
2026
Similar KOLs
Other experts from the same institution or the same specialty.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Jonathan Halperin, MD
Icahn School of Medicine at Mount Sinai
Fred Lublin, MD
Icahn School of Medicine at Mount Sinai
Sundar Jagannath, MD
Icahn School of Medicine at Mount Sinai
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”